A series of nickel complexes, 1b-3b, exhibiting subdued cytotoxicity have been designed with the intent of their use as agents for developing resistance to nickel toxicity. Indeed, the nickel complexes, 1b-3b, display less cytotoxic activity towards two commonly occurring human cancer cell lines namely, HeLa cells (16-64%) and MCF-7 cells (70-90%) in culture as compared to the maximum inhibition by NiCl 2 Á 6H 2 O under analogous conditions at three different concentrations (1 lM, 5 lM and 20 lM). Similarly, the suppression of cytotoxicity through chelation of the metal ion can also be seen in normal cells as was evident from a significant reduction in cytotoxicity (9-41%) for a non-tumorigenic CHO cell line in case of a representative complex 3b. The reduction in carcinogenic activity in the complexes relative to nickel(II) ion from NiCl 2 Á 6H 2 O is brought about by successful chelation of the metal center by a class of specially designed new tetradentate N/O-functionalized N-heterocyclic carbene ligands. The two strongly r-donating carbene moieties coupled with two negatively charged amido moieties present in the N-heterocyclic carbene ligands facilitate complete chelation of the metal center and thereby significantly reduce the cytotoxic effects of the metal.
Introduction
The day-to-day exposure to metals, including some very toxic ones like nickel, in varied amounts in occupational as well as in environmental settings pose a grave risk to public health in the modern era [1] . In this context, of particular relevance is nickel, which is a well-established human carcinogen that is frequently encountered in workplace and its surrounding environment and arise from its association with several important industrial processes that range from nickel mining and refining to electroplating to the production of much popular Ni-Cd batteries to the combustion of fossil fuels to the incineration of nickel-containing solid waste, etc. [2] . Furthermore, the release of nickel in the environment also contributes to significant non-occupational exposure [3] .
The counter strategy to thwart this menace involves reducing the cytotoxicity of the metal center by chelation with strongly binding ligands [4] . For example, this strategy has been successfully used for gadolinium, which by itself is extremely toxic, but when chelated with appropriate ligands, it exhibits subdued cytotoxicity and have been routinely used in radiotherapy for treatment of cancers [5] . A common methodology employed to develop resistance towards any useful but toxic metal, is the gradual exposure to a minute amount of the complex of the same metal. Such investigations are being successfully carried out in cases of nickel [6] and cadmium [7] .
Of late, there has been an interest in developing the chemistry of nickel complexes of N-heterocyclic carbene ligands, resulting in the synthesis of several such complexes supported over a wide variety of the NHC ligands. Quite a few applications of these Ni-NHC complexes have also been reported ranging from Suzuki cross coupling [8] to C-C and C-F activation [9] to olefin polymerization [10] to aryl Grignard cross coupling [11] to Heck reaction [12] , etc. As the biomedical studies of the Ni-NHC complexes have not yet been carried out, we became interested in exploring this area.
In this regard, our approach focuses on designing nickel compounds with significantly reduced carcinogenic activities for their potential applications in developing resistance to nickel toxicity. In particular, we planned to diminish the carcinogenic activity of the metal, as compared to its ionic state, Ni 2+ , by engulfing the metal through appropriate ligation. As our interest lies in exploring the utility of non-functionalized and N/O-functionalized N-heterocyclic carbenes [13] in biomedical applications [14] and in chemical catalysis [15] we chose to employ suitably tailored N/Ofunctionalized N-heterocylic carbene ligands for designing these nickel complexes with reduced carcinogenic activities. Furthermore, keeping the subdued cytotoxic activity in mind, we also planned in making these nickel complexes water soluble by putting polar functional groups as N-substituents on the N-heterocylic carbene ligands. Here, in this contribution, we report a series of nickel complexes namely, {N,N 0 -bis-{[2-(1-R)-imidazol-2-ylidene]acetyl}ethylenedi-amine}Ni [R = Me (1b), iPr (2b), CH 2 Ph (3b)], which are completely engulfed by a class of N/O-functionalized N-heterocylic carbene ligands and which show significantly reduced cytotoxicity with respect to NiCl 2 Á 6H 2 O and therefore are of interest as potential agents for developing resistance towards nickel cytotoxicity (Fig. 1 ).
Experimental

General procedures
All manipulations were carried out using a combination of a glovebox and standard Schlenk techniques. Solvents were purified and degassed by standard procedures. NiCl 2 Á 6H 2 O was purchased from SD-fine Chemicals (India) and 1-methylimidazole was purchased from Spectrochem Pvt. Ltd. (Mumbai, India) and were used without further purification. The 1-i-propylimidazole [16] and 1-benzylimidazole [17] were prepared according to the literature procedures.
1 H and 13 C{ 1 H} NMR spectra were recorded on a Varian 400 MHz NMR spectrometer. 1 H NMR peaks are labeled as singlet (s), doublet (d) , triplet (t), multiplet (m), and septet (sept). Infrared spectra were recorded on a Perkin-Elmer Spectrum One FT-IR spectrometer. X-ray diffraction data for 1b were collected on an Oxford Diffraction Excaliber-S diffractometer while 2b and 3b were collected on a Bruker APEX 2 CCD platform diffractometer. The crystal data collection and refinement parameters are summarized in Table S1 (Supplementary Supporting Information). The structures were solved using direct methods and standard difference map techniques, and were refined by full-matrix least-squares procedures on F 2 with SHELXTL (Version 6.10) [18] . (1a) N,N'-bis-(2-chloroacetyl)ethylenediamine (1.07 g, 5.02 mmol) and 1-methylimidazole (0.823 g, 10.0 mmol) were taken in toluene (ca. 10 mL) and refluxed overnight to obtain a light brown precipitate, which was isolated by decanting off the solvent. The residue was washed with hot hexane (ca. 15 mL) and dried under vacuum to obtain the product 1a as a light brown powder (1.03 g, 55% (2a) N,N'-bis-(2-chloroacetyl)ethylenediamine (1.07 g, 5.02 mmol) and 1-i-propylimidazole (1.10 g, 10.0 mmol) were taken in toluene (ca. 10 mL) and refluxed overnight to obtain a light brown precipitate, which was isolated by decanting off the solvent. The residue was washed with hot hexane (ca. 15 mL) and dried under vacuum to obtain the product 2a as a light brown powder (1.48 g, 68% , Calculated 361.2352.
N,N
0 -bis-{[2-(1-methyl)-imidazolium]acetyl}ethylenediamine dichloride2.4. N,N'-bis-{[2-(1-i-propyl)-imidazolium]acetyl}ethylenediamine dichloride
{N,N
acetyl}ethylenediamine dichloride (0.433 g, 1.00 mmol), NiCl 2 Á 6H 2 O (0.237 g, 1.00 mmol) and K 2 CO 3 (0.417 g, 3.02 mmol) were taken in CH 3 CN (ca. 30 mL). The reaction mixture was refluxed for 24 h, filtered and the solvent was removed. The residue was extracted in CH 2 Cl 2 , (ca. 20 mL) which was evaporated under vacuum to obtain the product 2b as a yellow solid (0.268 g, 64%). Single crystal of 2b was grown by slow evaporation method from a saturated CH 3 J H-H = 7 Hz, 2H, CH 2 ), 1.58 
N,N 0 -bis-(2-chloroacetyl)ethylenediamine (1.07 g, 5.02 mmol) and 1-benzylimidazole (1.59 g, 10.0 mmol) were taken in toluene (ca. 10 mL) and refluxed overnight to obtain a light brown precipitate, which was isolated by decanting off the solvent. The residue was washed with hot hexane (ca. 15 mL) and dried under vacuum to obtain the product 3a as a light brown powder (2.14 g, 81% 
acetyl}ethylenediamine dichloride (0.529 g, 1.00 mmol), NiCl 2 Á 6H 2 O (0.237 g, 1.00 mmol) and K 2 CO 3 (0.417 g, 3.02 mmol) were taken in CH 3 CN (ca. 30 mL). The reaction mixture was refluxed for 24 h, filtered and the solvent was removed. The residue was extracted in CH 2 Cl 2 , (ca. 20 mL) which was evaporated under vacuum to obtain the product 3b as a yellow solid (0.329 g, 64%). Single crystal of 3b was grown by slow evaporation method from a saturated CH 3 
Computational methods
Density functional theory calculations were performed on the three nickel complexes of N-heterocyclic carbenes, 1b-3b using GAUSSIAN 03 [19] suite of quantum chemical programs. The Becke three parameter exchange functional in conjunction with LeeYang-Parr correlation functional (B3LYP) has been employed in this study [20, 21] . The LANL2DZ basis set was used for the Ni atom [22] while all other atoms are treated with 6-31G(d) basis set [23] . All stationary points are characterized as minima by evaluating Hessian indices on the respective potential energy surfaces. Tight SCF convergence (10 À8 a.u.) was used for all calculations. Inspection of the metal-ligand donor-acceptor interactions was carried out using the charge decomposition analysis (CDA) [24] . CDA is a valuable tool in analyzing the interactions between molecular fragments on a quantitative basis, with an emphasis on the electron donation [25] . The orbital contributions in the NHC-Ni complexes, 1b-3b, can be divided into two parts:
(i) r-donation from the NHC ? Ni fragment and (ii) p-back donation from NHC Ni fragment
The CDA calculations are performed using the program AOMIX [26] using the B3LYP/LANL2DZ, 6-31G(d) wave function. Molecular orbital (MO) compositions and the overlap populations were calculated using the AOMIX Program. The analysis of the MO compositions in terms of occupied and unoccupied fragment orbitals (OFOs and UFOs, respectively), construction of orbital interaction diagrams, the charge decomposition analysis (CDA) were performed using the AOMIX-CDA [27] .
Biomedical application studies
Cell culture
Human cervical carcinoma (HeLa), Human breast cancer cells (MCF-7) and Chinese Hamster Ovary (CHO) cells were cultured in Eagle's Minimal Essential Medium (Himedia, Mumbai) supplemented with 10% fetal bovine serum, 2.2 g/L NaHCO 3 and 1% antibiotic-antimycotic solution (Himedia, Mumbai) containing streptomycin, amphoterecin B and penicillin. For MCF-7 cells, the medium was supplemented with 0.280 IU of insulin per mL of media. The cells were grown at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. on glass cover slips. A solution of following compounds, NiCl 2 Á 6H 2 O, 1a, 1b, 2a, 2b, 3a and 3b in DMSO (0.1% final concentration) were added to the culture medium 24 h after the seeding.
Cell proliferation
HeLa and MCF-7 cells (1 Â 10 5 /mL) were seeded on 96 well plates and grown in the absence and presence of different concentrations (1 lM, 5 lM and 20 lM) of NiCl 2 Á 6H 2 O, 1a, 1b, 2a, 2b, 3a and 3b at 37°C for one cell cycle. The effects of these compounds on the proliferation of HeLa and MCF-7 cells were determined using a standard sulforhodamine B assay [28] . Non-tumorigenic CHO cells (1 Â 10 5 /mL) were seeded on 96 well plates and grown in the presence and absence of NiCl 2 Á 6H 2 O, 3a and 3b. To see the effect of sequential addition of reaction components to form the functional nickel complex (3b) inside the CHO cells, the NiCl 2 Á 6H 2 O was added (1, 5, 20 lM) to CHO cells already seeded at a density of 1 Â 10 5 cells/mL. After 1 h, Cs 2 CO 3 was added
(1, 5, 20 lM) followed by the ligand 3a. The cells were incubated at 37°C in a humidified atmosphere of 5% CO 2 and 95% air. Data were the average of two independent experiments.
Differential interference contrast microscopy (DIC)
The effect of NiCl 2 Á 6H 2 O, 3a and 3b on the morphology of HeLa cells was analyzed by DIC microscopy. The cells (0.6 Â 10 5 cells/mL) seeded on glass cover slips were exposed to different concentrations (1, 5 and 20 lM) of the compounds and were examined with a Nikon Eclipse 2000-U microscope and the images were analyzed with image-Pro Plus software.
Results and discussion
With the objective of completely engulfing the nickel center, a new class of tetradentate ligand namely, {N,N'-bis-{[2-(1-R)-imida zol-2-ylidene]acetyl}ethylenediamine} [R = Me (1a) , iPr (2a), CH 2 Ph (3a)], was designed. Also, polar amido groups were chosen as N-substituents with the intention of making the nickel complexes water soluble. It was conceived that the tetradentate ligand containing two strongly r-donating carbene moieties and two polar amido moieties would effectively encapsulate the (8), C1-Ni1-N3 90.52 (7), C13-Ni1-N4 89.95 (7), N3-Ni1-N4 85.46 (7). Fig. 3 . Interaction of the filled carbene lone pairs and the amido groups of the free NHC ligand fragment with the unfilled 4s orbital of nickel in 1b-3b. nickel metal as favored by the entropy driven chelation process and, thus, was anticipated to suppress the high cytotoxicity of the bare nickel ion. The nickel complexes, 1b-3b were synthesized from the respective imidazolium dichloride salts, 1a-3a, by the direct reaction with NiCl 2 6H 2 O in presence of K 2 CO 3 as a base in 64-66% yield (Scheme 1). The distinctive metal bound carbene (C carbene -Ni) resonances appeared at 166.7 ppm (1b), 166.2 ppm (2b), and 166.0 ppm (3b) in the 13 C{ 1 H} NMR spectrum. Interestingly, the amido-NH protons were conspicuously absent in the 1 H NMR spectrum, which not only indicated their deprotonation during the reaction but also suggested the coordination of the amido groups to the metal. The ligand precursors, 1a-3a, were synthesized by alkylation of the respective imidazoles with N,N 0 -bis-(2-chloroacetyl)ethylenediamine in 55-81% yield (Scheme 1).
In order to check the stability of the nickel complexes in water, we recorded the 1 H NMR spectra in D 2 O, which closely resembled the spectra obtained in DMSO-d 6 . The water stable nature of 1b-3b is important particularly with regard to their utility in biomedical application studies. It is worth noting that though a few chelated nickel N-heterocyclic complexes are known, very little information pertaining to their water stability [29] , an important criterion for biomedical application studies, exist in the literature.
Indeed, in the molecular structures of 1b-3b, total chelation of the nickel center through tetradentate binding of the N-heterocyclic carbene ligands were observed (Fig. 2 and see Supplementary Supporting Information Figs. S1, S2 and Table S1 ). The geometry around the nickel center was found to be distorted square planar with the C carbene -Ni distances being 1.8670(19) Å and 1.8590(18) Å in 1b, 1.870(3) Å in 2b and 1.8644(15) Å and 1.8637 (16) Table S8 ). The NBO Analysis of the Ni-C carbene interaction revealed that the Ni-C carbene bond was composed of an interaction between the sp 2 C carbene orbital and the sd orbital of the Ni 2+ ion (see Supplementary Supporting Information, Table S9 ). Furthermore, the Charge Decomposition Analysis (CDA) performed on Ni-C carbene interaction of the 1b-3b complexes revealed that the Ni-NHC interaction comprised of (NHC ! Table S10 ). Indeed, a careful look at the simplified molecular orbital correlation diagrams of 1b-3b, constructed to understand the binding of the NHC ligand fragment with the metal center, reveal that the carbene lone pairs along with the amido groups of the free NHC ligand fragment interacted with the unfilled 4s orbital of nickel center ( Fig. 3 and see Supplementary Supporting Information Figures S3-S5 ). This overall interaction of the NHC ligand with the nickel based orbital can be observed in the following orbitals, , and . As these NHC-nickel r-bonding molecular orbitals are deeply buried, they essentially contribute to the inert nature of the NHC-nickel interaction, which in turn causes the exceptional stability of these complexes. Quite significantly, the biomedical application studies carried out on 1b-3b relative to that of the NiCl 2 Á 6H 2 O showed that 1b-3b exhibited remarkably reduced cytotoxic activity compared to that of NiCl 2 Á 6H 2 O under analogous conditions. Specifically, cell proliferation studies carried out at three different concentrations (1, 5 and 20 lM) in presence of 1b-3b on two commonly available human cancer cell lines namely, HeLa and MCF-7 cell lines in culture, showed significant reduction of the cytotoxic activity [(16-64%) for HeLa cells and (70-90%) for MCF-7 cells] for all the nickel complexes in both the cell lines (see Tables 1 and 2 ). It is worth noting that the significant reduction of the cytotoxic properties of 1b-3b, compared to that of otherwise very toxic Ni(II) ion in NiCl 2 Á 6H 2 O is brought about by successful chelation of the nickel center in these complexes by the strongly r-donating tetradentate N-heterocyclic carbene ligands. More interestingly, owing to its subdued cytotoxic properties, these complexes, 1b-3b, may find utility as agents for developing resistance to nickel toxicity. Experiments similar to the effect of NiCl 2 Á 6H 2 O, NHC ligands and the nickel complexes on HeLa and MCF-7 cells were repeated on non-tumorigenic CHO cells by employing a representative ligand 3a and its nickel complex 3b (Table 3) . The results showed no difference in selectivity of these compounds towards tumorigenic and non-tumorigenic cells. For example, NiCl 2 Á 6H 2 O exhibited similar cytotoxicity in CHO cells as compared to HeLa and MCF-7 cells and its cytotoxicity decreased when complexed with the NHC ligand.
Further experiments were carried out in order to examine the ability of the NHC ligand to suppress the cytotoxicity arising out of Ni(II) species. Specifically, when the non-tumorigenic CHO cells were exposed to NiCl 2 Á 6H 2 O for 1 h followed by subsequent addition of the ligand 3a in presence of Cs 2 CO 3 , similar cytotoxic effect as compared to NiCl 2 Á 6H 2 O on CHO cells were observed at all concentrations, thereby suggesting that the sequential addition of the reactants, 3a and NiCl 2 Á 6H 2 O in the presence of Cs 2 CO 3 , failed to result in the intracellular complex (3b) formation (Table 4 ). The observed cytotoxicity in the experiment was very similar to that of NiCl 2 Á 6H 2 O. In this regard, it is worth noting that all of the nickel complexes 1b-3b were synthesized under harsher refluxing conditions as compared to the mild cellular conditions. The control experiment using only Cs 2 CO 3 showed that it has no cytotoxic effect on CHO cells at all concentrations.
In order to directly observe the effect of the nickel on the cancer cell lines, morphological studies were carried out using differential interference contrast (DIC) microscopy. In particular, the experiments, which were carried out at three different concentrations (1, 5 and 20 lM) on HeLa cells in presence of NiCl 2 Á 6H 2 O, a representative nickel complex 3b and its ligand, 3a, showed that while severe blebbing (erupted spots) for the dying cells were observed in case of NiCl 2 Á 6H 2 O, no such surface abnormalities were seen in case of the representative nickel complex 3b and its ligand, 3a (see Fig. 4 and Supplementary Supporting Information Figs. S6 and S7). These observations further substantiate the fact that drastic reduction in the cytotoxic activity of nickel was successfully achieved by encapsulation of the metal center in 1b-3b by employing a new class of tightly binding N-heterocylic carbene ligand.
Conclusions
In summary, a series of nickel complexes, 1b-3b, displaying significantly subdued cytotoxic activity towards two commonly available human cancer cell lines namely, HeLa cells and MCF-7 cells, and one non-tumorigenic cell line, CHO cells, in culture as compared to the maximum inhibition by NiCl 2 Á 6H 2 O under analogous conditions, have been designed. Furthermore, morphological studies on HeLa cells showed that a representative complex, 3b, caused minimum surface abnormality on the cancer cells consistent with its reduced cytotoxic activity.
